Figs Inc. logo

Figs Inc. (FIGS)

Market Closed
12 Dec, 20:00
NYSE NYSE
$
11. 90
+0.22
+1.93%
$
1.59B Market Cap
38.83 P/E Ratio
0% Div Yield
1,460,616 Volume
0.07 Eps
$ 11.68
Previous Close
Day Range
11.72 12.01
Year Range
3.56 12.21
Want to track FIGS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 75 days
FIGS, Inc. (FIGS) Q4 2024 Earnings Call Transcript

FIGS, Inc. (FIGS) Q4 2024 Earnings Call Transcript

FIGS, Inc. (NYSE:FIGS ) Q4 2024 Earnings Conference Call February 27, 2025 5:00 PM ET Company Participants Tom Shaw - Senior Vice President, Investor Relations Trina Spear - Co-Founder & Chief Executive Officer Sarah Oughtred - Chief Financial Officer Conference Call Participants Brooke Roach - Goldman Sachs Brian Nagel - Oppenheimer John Kernan - TD Cowen Dana Telsey - Telsey Group Lorraine Hutchinson - Bank of America Matt Koranda - ROTH Capital Ashley Owens - KeyBanc Capital Markets Nathan Feather - Morgan Stanley Operator Good afternoon, everyone, and thank you for joining today's FIGS Fourth Quarter Fiscal 2024 Earnings Conference Call. My name is Reagan, and I'll be your moderator today.

Seekingalpha | 9 months ago
Figs (FIGS) Q4 Earnings Meet Estimates

Figs (FIGS) Q4 Earnings Meet Estimates

Figs (FIGS) came out with quarterly earnings of $0.01 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.05 per share a year ago.

Zacks | 9 months ago
Countdown to Figs (FIGS) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS

Countdown to Figs (FIGS) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS

Beyond analysts' top -and-bottom-line estimates for Figs (FIGS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2024.

Zacks | 9 months ago
Scrubs maker Figs rebuffs Story3 Capital's take-private offer

Scrubs maker Figs rebuffs Story3 Capital's take-private offer

Figs said on Thursday it has rebuffed private equity firm Story3 Capital Partners' offer to acquire the scrubs maker.

Reuters | 11 months ago
Figs stock price sits in a range: will it have a breakout in 2025?

Figs stock price sits in a range: will it have a breakout in 2025?

Figs stock has lost momentum and remained in a consolidation phase in almost two years. It remained inside the support and resistance levels at $4.42 and $6.97 in this period, missing the strong stock surge in the United States.

Invezz | 11 months ago
FIGS: Opportunistic Bid Grossly Undervalues A Recession Proof Business

FIGS: Opportunistic Bid Grossly Undervalues A Recession Proof Business

An opportunistic offer by a PE fund during a 'retail lull' grossly undervalues FIGS, thus providing a chance for value and arbitrage investors to profit from the situation. Founded by Heather Hasson and Trina Spear, the stock has dropped from over $35 to $6.07 since its 2021 IPO and subsequent takeover offer. Story3 Capital's $6 per share offer to take the company private undervalues the business, which has strong free cash flow and no debt.

Seekingalpha | 0 year ago
Is Figs a Buy After $1 Billion Buyout Rumors?

Is Figs a Buy After $1 Billion Buyout Rumors?

Shares of Figs (FIGS -3.85%) jumped this week after the company reportedly received a buyout offer for around $1 billion. In this video, Travis Hoium shows why private equity buyers may be interested and what the stock could do now.

Fool | 0 year ago
Medical-Apparel Maker Figs Gets Takeover Bid From Private-Equity Firm

Medical-Apparel Maker Figs Gets Takeover Bid From Private-Equity Firm

The Story3 proposal values the company at more than $1 billion.

Wsj | 1 year ago
Medical-Apparel Maker Figs Gets Takeover Bid From Private-Equity Firm

Medical-Apparel Maker Figs Gets Takeover Bid From Private-Equity Firm

The Story3 proposal values the company at more than $1 billion.

Wsj | 1 year ago
FIGS Back To Q1 Prices, But The Name Is Still A Hold

FIGS Back To Q1 Prices, But The Name Is Still A Hold

Figs reported disappointing 3Q24 results with a 2% revenue decline and a 13 percentage point drop in adjusted EBITDA margins, leading to a 30% stock price drop. The company's high SG&A expenses and lack of growth make it difficult to compete against lower-priced alternatives, justifying my Hold rating. Questionable $25 million investment in a pre-product healthcare education app raises concerns about capital allocation and potential conflicts of interest.

Seekingalpha | 1 year ago
FIGS, Inc. (FIGS) Q3 2024 Earnings Call Transcript

FIGS, Inc. (FIGS) Q3 2024 Earnings Call Transcript

FIGS, Inc. (NYSE:FIGS ) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Tom Shaw - Senior Vice President, Investor Relations Trina Spear - Co-Founder & Chief Executive Officer Sarah Oughtred - Chief Financial Officer Conference Call Participants Dana Telsey - Telsey Group Josh Reiss - Raymond James Bob Drbul - Guggenheim Brooke Roach - Goldman Sachs Brian Nagel - Oppenheimer Lorraine Hutchinson - Bank of America Matt Koranda - ROTH Capital Nathan Feather - Morgan Stanley John Kernan - TD Cowen Ashley Owens - KeyBanc Capital Markets Operator Thank you for standing by, and good afternoon. Thank you for attending today's FIGS' Third Quarter Fiscal 2024 Earnings Conference Call.

Seekingalpha | 1 year ago
Figs (FIGS) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

Figs (FIGS) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

Although the revenue and EPS for Figs (FIGS) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks | 1 year ago
Loading...
Load More